Atlas Venture

VC firm · Boston, MA

Verified active in the last 12 monthsSEC-registered adviser

Venture firm based in Boston, MA. Most recent fund on file: Atlas Venture Opportunity Fund Ill, L.P. ($400M offering), filed Sep 2025. Partners sit on the boards of 9 startups that raised recently.

“Thirty years at the leading-edge of medical innovation and we’re just getting started.” (from the firm’s website)

Stages: Series B, Growth
Typical check (est.): $4M–$12M
Latest fund: $400M · Sep 2025
Last verified activity: Jan 2026

Focus

Biotech & Pharma

Recent portfolio activity

Caldera Therapeutics
Board seat · MA
Jan 2026
Triana Biomedicines
Board seat · MA
Dec 2025
Affinia Therapeutics
Board seat · MA
Oct 2025
Renasant Bio
Board seat · CA
Jul 2025
GRO Biosciences
Board seat · MA
Jul 2024
Remix Therapeutics
Board seat · MA
Jan 2024
Kinaset Therapeutics
Board seat · MA
Jul 2023
Comanche Biopharma
Board seat · MA
May 2023
Chroma Medicine
Board seat · MA
Mar 2023

Funds and vehicles on SEC file

Atlas Venture Opportunity Fund Ill, L.P.
Fund · $400M offering
Sep 2025
Atlas Venture Fund XIV, L.P.
Fund · $450M offering
Dec 2024

Sources

SEC Form D: Atlas Venture Opportunity Fund Ill, L.P.Sep 4, 2025
SEC Form D: Atlas Venture Fund XIV, L.P.Dec 5, 2024
SEC adviser record: Atlas VentureMar 30, 2026
Firm websiteOct 12, 2026

Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.